Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $7000.0.

  • Harmony Biosciences Holdings' Depreciation & Amortization (CF) changed 0.0% to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $26000.0, marking a year-over-year decrease of 9388.24%. This contributed to the annual value of $267000.0 for FY2024, which is 4805.45% down from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Depreciation & Amortization (CF) is $7000.0, which was down 0.0% from $6000.0 recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Depreciation & Amortization (CF) ranged from a high of $164000.0 in Q4 2023 and a low of $6000.0 during Q4 2024
  • In the last 5 years, Harmony Biosciences Holdings' Depreciation & Amortization (CF) had a median value of $100000.0 in 2021 and averaged $86105.3.
  • The largest annual percentage gain for Harmony Biosciences Holdings' Depreciation & Amortization (CF) in the last 5 years was 5825.24% (2024), contrasted with its biggest fall of 9634.15% (2024).
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Depreciation & Amortization (CF) stood at $117000.0 in 2021, then decreased by 8.55% to $107000.0 in 2022, then soared by 53.27% to $164000.0 in 2023, then tumbled by 96.34% to $6000.0 in 2024, then grew by 16.67% to $7000.0 in 2025.
  • Its last three reported values are $7000.0 in Q3 2025, $6000.0 for Q2 2025, and $7000.0 during Q1 2025.